共 50 条
- [31] A Phase 2 trial of sipuleucel-T in combination with concurrent or sequential abiraterone acetate (AA) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)EUROPEAN JOURNAL OF CANCER, 2013, 49 : S682 - S683Small, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USALance, R.论文数: 0 引用数: 0 h-index: 0机构: Eastern Virginia Med Sch, Norfolk, VA 23501 USA Univ Calif San Francisco, San Francisco, CA 94143 USAGardner, T. A.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ Sch Med, Indianapolis, IN 46202 USA Univ Calif San Francisco, San Francisco, CA 94143 USAKarsh, L. I.论文数: 0 引用数: 0 h-index: 0机构: Urol Ctr Colorado, Denver, CO USA Univ Calif San Francisco, San Francisco, CA 94143 USAStubbs, A.论文数: 0 引用数: 0 h-index: 0机构: Dendreon Corp, Seattle, WA USA Univ Calif San Francisco, San Francisco, CA 94143 USAMcCoy, C.论文数: 0 引用数: 0 h-index: 0机构: Dendreon Corp, Seattle, WA USA Univ Calif San Francisco, San Francisco, CA 94143 USADeVries, T.论文数: 0 引用数: 0 h-index: 0机构: Dendreon Corp, Seattle, WA USA Univ Calif San Francisco, San Francisco, CA 94143 USARedfern, C. H.论文数: 0 引用数: 0 h-index: 0机构: Sharp Healthcare, San Diego, CA USA Univ Calif San Francisco, San Francisco, CA 94143 USAShore, N. D.论文数: 0 引用数: 0 h-index: 0机构: 7Carolina Urol Res Ctr, Myrtle Beach, SC USA Univ Calif San Francisco, San Francisco, CA 94143 USA
- [32] ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)ANNALS OF ONCOLOGY, 2018, 29Smith, M. R.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USA Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAParker, C. C.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, Dept Urol, Inst Canc Res, Sutton, Surrey, England Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USASaad, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Montreal Hosp Ctr, Dept Urol, Montreal, PQ, Canada Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAMiller, K.论文数: 0 引用数: 0 h-index: 0机构: Charite, Dept Med Oncol, Berlin, Germany Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USATombal, B.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ St Luc, Dept Urol, Brussels, Belgium Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USANg, Q. S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USABoegemann, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Munster, Med Ctr, Dept Clin Oncol Urol, Munster, Germany Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAMatveev, V.论文数: 0 引用数: 0 h-index: 0机构: NN Blokhin Canc Res Ctr, Dept Urol, Moscow, Russia Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAPiulats, J. M.论文数: 0 引用数: 0 h-index: 0机构: Catalan Canc Inst, Dept Med Oncol, Barcelona, Spain Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAZucca, L. E.论文数: 0 引用数: 0 h-index: 0机构: Barretos Canc Hosp, Dept Med Oncol, Barretos, Brazil Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAHeidenreich, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Cologne, Dept Urol, Cologne, Germany Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAKakehi, Y.论文数: 0 引用数: 0 h-index: 0机构: Kagawa Univ, Dept Urol, Takamatsu, Kagawa, Japan Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAZhang, A.论文数: 0 引用数: 0 h-index: 0机构: Bayer HealthCare Pharmaceut, Oncol, Whippany, NJ USA Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAKrissel, H.论文数: 0 引用数: 0 h-index: 0机构: Bayer AG, Oncol, Berlin, Germany Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAShen, J.论文数: 0 引用数: 0 h-index: 0机构: Bayer HealthCare Pharmaceut, Clin Stat, Whippany, NJ USA Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAWagner, V.论文数: 0 引用数: 0 h-index: 0机构: Bayer Consumer Care AG, Oncol, Basel, Switzerland Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USAHigano, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med Oncol, Seattle, WA 98195 USA Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USA
- [33] Biomarker analysis of the phase III IPATential150 trial of first-line ipatasertib (Ipat) plus abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC)JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)Shi, Zhen论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USASweeney, Christopher论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USABracarda, Sergio论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USASternberg, Cora N.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USAChi, Kim N.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USAOlmos, David论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USASandhu, Shahneen Kaur论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USAMassard, Christophe论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USAMatsubara, Nobuaki论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USAHarle-Yge, Marie-Laurence论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USANowicka, Malgorzata论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USAWongchenko, Matthew论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USADe Bono, Johann S.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA
- [34] Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate CancerJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (02) : 76 - +Michaelson, M. Dror论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAOudard, Stephane论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, George Pompidou European Hosp, Paris, France Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAOu, Yen-Chuan论文数: 0 引用数: 0 h-index: 0机构: Taichung Vet Gen Hosp, Taichung, Taiwan Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USASengelov, Lisa论文数: 0 引用数: 0 h-index: 0机构: Herlev Hosp, DK-2730 Herlev, Denmark Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA论文数: 引用数: h-index:机构:Houede, Nadine论文数: 0 引用数: 0 h-index: 0机构: Inst Bergonie, Bordeaux, France Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAOstler, Peter论文数: 0 引用数: 0 h-index: 0机构: Mt Vernon Hosp, Northwood HA6 2RN, Middx, England Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAStenzl, Arnulf论文数: 0 引用数: 0 h-index: 0机构: Univ Tubingen, Sch Med, Tubingen, Germany Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USADaugaard, Gedske论文数: 0 引用数: 0 h-index: 0机构: Rigshosp, DK-2100 Copenhagen, Denmark Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAJones, Robert论文数: 0 引用数: 0 h-index: 0机构: Beatson West Scotland Canc, Glasgow, Lanark, Scotland Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USALaestadius, Fredrik论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp, Stockholm, Sweden Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAUllen, Anders论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp, Stockholm, Sweden Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USABahl, Amit论文数: 0 引用数: 0 h-index: 0机构: Bristol Haematol & Oncol Ctr, Bristol, Avon, England Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USACastellano, Daniel论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp 12 Octubre, Res Inst I 12, Madrid, Spain Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAGschwend, Juergen论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Munich, D-80290 Munich, Germany Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAMaurina, Tristan论文数: 0 引用数: 0 h-index: 0机构: Hop Jean Minjoz, CHU Besancon, F-25030 Besancon, France Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAManeval, Edna Chow论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, La Jolla, CA USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAWang, Shaw-Ling论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, La Jolla, CA USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USALechuga, Maria Jose论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, Milan, Italy Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAPaolini, Jolanda论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, Milan, Italy Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USAChen, Isan论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, La Jolla, CA USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
- [35] A randomized phase II cross-over study of abiraterone plus prednisone (ABI) vs enzalutamide (ENZ) for patients (pts) with metastatic, castration resistant prostate cancer (mCRPC).JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Chi, Kim N.论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaAnnala, Matti论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaSunderland, Katherine论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaKhalaf, Daniel论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaFinch, Daygen论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaOja, Conrad D.论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaVergidis, Joanna论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaZulfiqar, Muhammad论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaBeja, Kevin论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaVandekerkhove, Gillian论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaGleave, Martin论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, CanadaWyatt, Alexander William论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC, Canada
- [36] A randomized phase II, open-label study of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC)JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)Small, Eric Jay论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USALance, Raymond论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USAGardner, Thomas A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USAKarsh, Lawrence Ivan论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USAStubbs, Andrew论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USAMcCoy, Candice论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USADeVries, Todd论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USARedfern, Charles H.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USAShore, Neal D.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA
- [37] Multimodal detection of homologous recombination repair gene mutations (HRRm) in a phase II trial of olaparib plus abiraterone in metastatic castrate resistant prostate cancer (mCRPC)ANNALS OF ONCOLOGY, 2018, 29Carr, T. H.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandAdelman, C.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandBarnicle, A.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandKozarewa, I.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandLuke, S.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandLai, Z.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gaithersburg, MD USA AstraZeneca, Cambridge, EnglandMenon, S.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandHollis, S.论文数: 0 引用数: 0 h-index: 0机构: Phastar, London, England AstraZeneca, Cambridge, EnglandDougherty, B.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gaithersburg, MD USA AstraZeneca, Cambridge, EnglandHarrington, E. A.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandBarrett, J. C.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gaithersburg, MD USA AstraZeneca, Cambridge, EnglandGoessl, C.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gaithersburg, MD USA AstraZeneca, Cambridge, EnglandSaad, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Montreal, Hosp Res Ctr, Montreal, PQ, Canada AstraZeneca, Cambridge, EnglandSala, N.论文数: 0 引用数: 0 h-index: 0机构: Hosp Josep Trueta, Catalan Inst Oncol, Girona, Spain AstraZeneca, Cambridge, EnglandClarke, N. W.论文数: 0 引用数: 0 h-index: 0机构: Christie NHS Fdn Trust, Manchester, Lancs, England AstraZeneca, Cambridge, EnglandHodgson, D.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, England
- [38] Randomized phase II trial of docetaxel (Doc) and prednisone (Pred) with or without AZD2171 (cediranib), in chemotherapy-naive, metastatic castrate-resistant prostate cancer (mCRPC) (NCI 7451)JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)Heath, Elisabeth I.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAMannuel, Heather Dorothy论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USALiu, Glenn论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USALara, Primo论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAMonk, J. P.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAFlaig, Thomas W.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAZurita, Amado J.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAVaishampayan, Ulka N.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAStella, Philip J.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USASmith, Daryn W.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USADobson, Kimberlee论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAHussain, Arif论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAAl-Janadi, Anas论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAIvy, S. Percy论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USAHeilbrun, Lance K.论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USA
- [39] CABAZITAXEL PLUS PREDNISONE/PREDNISOLONE SIGNIFICANTLY INCREASES OVERALL SURVIVAL COMPARED TO MITOXANTRONE PLUS PREDNISONE/PREDNISOLONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: FINAL RESULTS WITH UPDATED OVERALL SURVIVAL OF A MULTINATIONAL PHASE III TRIAL (TROPIC)ANNALS OF ONCOLOGY, 2010, 21 : 272 - 272Oudard, S. M.论文数: 0 引用数: 0 h-index: 0机构: Hop Europeen Georges Pompidou, Paris, France Hop Europeen Georges Pompidou, Paris, FranceDe Bono, J. S.论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res, Sutton, Surrey, England Royal Marsden Natl Hlth Serv Fdn Trust, Sutton, Surrey, England Hop Europeen Georges Pompidou, Paris, FranceOzguroglu, M.论文数: 0 引用数: 0 h-index: 0机构: Istanbul Univ, Istanbul, Turkey Hop Europeen Georges Pompidou, Paris, FranceHansen, S.论文数: 0 引用数: 0 h-index: 0机构: Odense Univ Hosp, DK-5000 Odense, Denmark Hop Europeen Georges Pompidou, Paris, FranceMachiels, J.论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium Hop Europeen Georges Pompidou, Paris, FranceShen, L.论文数: 0 引用数: 0 h-index: 0机构: Sanofi Aventis, Malvern, PA USA Hop Europeen Georges Pompidou, Paris, FranceGupta, S.论文数: 0 引用数: 0 h-index: 0机构: Sanofi Aventis, Malvern, PA USA Hop Europeen Georges Pompidou, Paris, FranceSartor, A. O.论文数: 0 引用数: 0 h-index: 0机构: Tulane Univ, New Orleans, LA 70118 USA Hop Europeen Georges Pompidou, Paris, France
- [40] Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trialLANCET, 2021, 398 (10295): : 131 - 142论文数: 引用数: h-index:机构:Bracarda, Sergio论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Santa Maria, Terni, Italy Dana Farber Canc Inst, Boston, MA 02115 USASternberg, Cora N.论文数: 0 引用数: 0 h-index: 0机构: New York Presbyterian, Englander Inst Precis Med, Weill Cornell Med, New York, NY USA Dana Farber Canc Inst, Boston, MA 02115 USAChi, Kim N.论文数: 0 引用数: 0 h-index: 0机构: BC Canc, Vancouver, BC, Canada Dana Farber Canc Inst, Boston, MA 02115 USAOlmos, David论文数: 0 引用数: 0 h-index: 0机构: Spanish Natl Canc Res Ctr CNIO, Malaga, Spain Inst Invest Biomed Malaga IBIMA, Malaga, Spain Dana Farber Canc Inst, Boston, MA 02115 USASandhu, Shahneen论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Univ Melbourne, Melbourne, Vic, Australia Dana Farber Canc Inst, Boston, MA 02115 USAMassard, Christophe论文数: 0 引用数: 0 h-index: 0机构: Inst Gustave Roussy, Villejuif, France Dana Farber Canc Inst, Boston, MA 02115 USAMatsubara, Nobuaki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Chiba, Japan Dana Farber Canc Inst, Boston, MA 02115 USAAlekseev, Boris论文数: 0 引用数: 0 h-index: 0机构: PA Herzen Moscow Oncol Res Inst, Moscow, Russia Dana Farber Canc Inst, Boston, MA 02115 USAParnis, Francis论文数: 0 引用数: 0 h-index: 0机构: Ashford Canc Ctr Res, Kurralta Pk, SA, Australia Dana Farber Canc Inst, Boston, MA 02115 USAAtduev, Vagif论文数: 0 引用数: 0 h-index: 0机构: Volga Dist Med Ctr Fed Med & Biol Agcy Russia, Nizhnii Novgorod, Russia Dana Farber Canc Inst, Boston, MA 02115 USABuchschacher, Gary L., Jr.论文数: 0 引用数: 0 h-index: 0机构: Kaiser Permanente Southern Calif, Los Angeles Med Ctr, Los Angeles, CA USA Dana Farber Canc Inst, Boston, MA 02115 USAGafanov, Rustem论文数: 0 引用数: 0 h-index: 0机构: Russian Sci Ctr Roentgenol & Radiol, Moscow, Russia Dana Farber Canc Inst, Boston, MA 02115 USACorrales, Luis论文数: 0 引用数: 0 h-index: 0机构: Ctr Invest & Manejo Canc CIMCA, Med Oncol, San Jose, Costa Rica Dana Farber Canc Inst, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Stroyakovskiy, Daniil论文数: 0 引用数: 0 h-index: 0机构: Moscow City Oncol Hosp 62, Moscow Healthcare Dept, Moscow, Moscow Oblast, Russia Dana Farber Canc Inst, Boston, MA 02115 USAAlves, Gustavo Vasconcelos论文数: 0 引用数: 0 h-index: 0机构: Hosp Nossa Senhora Conceicao, Ctr Integrad Pesquisa Oncol, Porto Alegre, RS, Brazil Dana Farber Canc Inst, Boston, MA 02115 USABournakis, Evangelos论文数: 0 引用数: 0 h-index: 0机构: Metropolitan Gen Hosp, Oncol Clin Trials & Res Clin, Athens, Greece Dana Farber Canc Inst, Boston, MA 02115 USAPuente, Javier论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, CIBERONC, Madrid, Spain Dana Farber Canc Inst, Boston, MA 02115 USAHarle-Yge, Marie-Laurence论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Dana Farber Canc Inst, Boston, MA 02115 USAGallo, Jorge论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Dana Farber Canc Inst, Boston, MA 02115 USAChen, Geng论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Dana Farber Canc Inst, Boston, MA 02115 USAHanover, Justin论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Dana Farber Canc Inst, Boston, MA 02115 USAWongchenko, Matthew J.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Dana Farber Canc Inst, Boston, MA 02115 USAGarcia, Josep论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Dana Farber Canc Inst, Boston, MA 02115 USAde Bono, Johann S.论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res, Div Clin Studies, London SM2 5PT, England Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England Dana Farber Canc Inst, Boston, MA 02115 USA